ATE427122T1 - Behandlung von dermatitis mit dehydroepiandrosteron-glucocorticoid- kombinationen - Google Patents
Behandlung von dermatitis mit dehydroepiandrosteron-glucocorticoid- kombinationenInfo
- Publication number
- ATE427122T1 ATE427122T1 AT05807524T AT05807524T ATE427122T1 AT E427122 T1 ATE427122 T1 AT E427122T1 AT 05807524 T AT05807524 T AT 05807524T AT 05807524 T AT05807524 T AT 05807524T AT E427122 T1 ATE427122 T1 AT E427122T1
- Authority
- AT
- Austria
- Prior art keywords
- glucocorticoid
- dehydroepiandrosterone
- dermatitis
- combinations
- treatment
- Prior art date
Links
- 239000003862 glucocorticoid Substances 0.000 title abstract 3
- 201000004624 Dermatitis Diseases 0.000 title abstract 2
- FMGSKLZLMKYGDP-USOAJAOKSA-N dehydroepiandrosterone Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC=C21 FMGSKLZLMKYGDP-USOAJAOKSA-N 0.000 abstract 1
- 230000009885 systemic effect Effects 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61271704P | 2004-09-24 | 2004-09-24 | |
| US11/108,032 US8084444B2 (en) | 2004-09-24 | 2005-04-15 | Treatment of dermatitis with dehydroepiandrosterone-glucocorticoid combinations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE427122T1 true ATE427122T1 (de) | 2009-04-15 |
Family
ID=36100080
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05807524T ATE427122T1 (de) | 2004-09-24 | 2005-09-08 | Behandlung von dermatitis mit dehydroepiandrosteron-glucocorticoid- kombinationen |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8084444B2 (de) |
| EP (1) | EP1824515B1 (de) |
| AT (1) | ATE427122T1 (de) |
| CA (1) | CA2581364A1 (de) |
| DE (1) | DE602005013690D1 (de) |
| DK (1) | DK1824515T3 (de) |
| ES (1) | ES2321857T3 (de) |
| PL (1) | PL1824515T3 (de) |
| WO (1) | WO2006036484A2 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2329837C2 (ru) * | 2006-09-13 | 2008-07-27 | ФГУ "Уральский научно-исследовательский институт дерматологии и иммунопатологии Росздрава" (УрНИИДВиИ) | Способ лечения атопического дерматита |
| ES2539952T3 (es) | 2008-06-30 | 2015-07-07 | Schwartz, Arthur | Formulaciones esteroideas tópicas |
| US20100086581A1 (en) * | 2008-10-07 | 2010-04-08 | Ernest Bove | Method for purpura reduction and prevention |
| US20120245552A1 (en) * | 2011-03-23 | 2012-09-27 | Pop Test Cortisol Llc | Combination Therapy |
| US10045981B2 (en) | 2015-11-24 | 2018-08-14 | Jakpharm, Llc | Selective kinase inhibitors |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4496556A (en) * | 1982-08-16 | 1985-01-29 | Norman Orentreich | Topical applications for preventing dry skin |
| WO1994008589A1 (en) * | 1992-10-09 | 1994-04-28 | The Board Of Trustees Of The Leland Stanford Junior University | Treatment of systemic lupus erythematosus with dehydroepiandrosterone |
| WO1995015746A1 (en) * | 1993-12-10 | 1995-06-15 | The School Of Pharmacy | Liposome delivery systems |
| JPH07258091A (ja) * | 1994-03-17 | 1995-10-09 | Kyowa Hakko Kogyo Co Ltd | アトピー性皮膚炎治療剤 |
| GB9612990D0 (en) * | 1996-06-20 | 1996-08-21 | Stanford Rock Ltd | Compositions and methods for the treatment of chronic infections |
| US5861391A (en) * | 1997-01-29 | 1999-01-19 | Research Development Foundation | Use of dehydroepiandrosterone to treat primary adrenal insufficiency and Addison's disease |
| US6479058B1 (en) * | 1999-09-02 | 2002-11-12 | Mccadden Michael E. | Composition for the topical treatment of poison ivy and other forms of contact dermatitis |
| US6552010B1 (en) * | 1999-11-12 | 2003-04-22 | Genelabs Technologies, Inc. | Treatment of SLE with dehydroepiandrosterone |
| US6787532B2 (en) * | 2000-08-05 | 2004-09-07 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivatives |
| FR2848844B1 (fr) * | 2002-12-18 | 2005-05-06 | Oreal | Utilisation d'un alkylether d'hydroxystilbene pour le traitement des peaux seches |
-
2005
- 2005-04-15 US US11/108,032 patent/US8084444B2/en active Active
- 2005-09-08 PL PL05807524T patent/PL1824515T3/pl unknown
- 2005-09-08 DK DK05807524T patent/DK1824515T3/da active
- 2005-09-08 EP EP05807524A patent/EP1824515B1/de not_active Expired - Lifetime
- 2005-09-08 WO PCT/US2005/031850 patent/WO2006036484A2/en not_active Ceased
- 2005-09-08 AT AT05807524T patent/ATE427122T1/de not_active IP Right Cessation
- 2005-09-08 CA CA002581364A patent/CA2581364A1/en not_active Abandoned
- 2005-09-08 ES ES05807524T patent/ES2321857T3/es not_active Expired - Lifetime
- 2005-09-08 DE DE602005013690T patent/DE602005013690D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2581364A1 (en) | 2006-04-06 |
| WO2006036484A3 (en) | 2006-06-01 |
| EP1824515B1 (de) | 2009-04-01 |
| DK1824515T3 (da) | 2009-06-29 |
| PL1824515T3 (pl) | 2009-08-31 |
| EP1824515A2 (de) | 2007-08-29 |
| ES2321857T3 (es) | 2009-06-12 |
| DE602005013690D1 (de) | 2009-05-14 |
| US20060069071A1 (en) | 2006-03-30 |
| US8084444B2 (en) | 2011-12-27 |
| WO2006036484A2 (en) | 2006-04-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA88464C2 (ru) | Способ дермального введения метадоновой композиции с обеспечением системного действия | |
| EP1587834A4 (de) | Verwendungen von säuger-cytokin; verwandte reagenzien | |
| DE60313597D1 (de) | Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis | |
| NO20081790L (no) | Topiske formuleringer | |
| NO20054988D0 (no) | Preparater og metoder for behandling av cancer | |
| MX2007000979A (es) | Tratamiento de la hipertension pulmonar por iloprost inhalado con una formulacion microparticulada. | |
| NO20070372L (no) | Amidoforbindelser og anvendelse derav som farmasoytiske preparater | |
| BR112014012444A2 (pt) | formulações e terapias de reposição hormonal natural combinada | |
| ATE448777T1 (de) | Mittel für die transdermale verabreichung von nikotin | |
| WO2012100097A3 (en) | Topical minocycline compositions and methods of using the same | |
| MY161021A (en) | Controlled release corticosteroid and methods for the treatment of otic disorders | |
| ATE359065T1 (de) | Verwendung von einem insulin-sensibilisator in der behandlung von alopecia | |
| DE50312034D1 (de) | Liposomale glucocorticoide | |
| WO2002047611A3 (en) | Cddo-compounds and combination therapies thereof | |
| DE60327103D1 (de) | Darreichungsformen enthaltend einen protonpumphemmer, einen nsaid und einen puffer | |
| NO20076004L (no) | Ustadige hoyt ladete konsentratblandinger for kontroll av ektoparasitter | |
| ATE404206T1 (de) | Orale suspension mit meloxicam | |
| SE0300971D0 (sv) | Nitric oxide in treatment of inflammation | |
| DE602004013035D1 (de) | Suspension von loteprednol-etabonat und tobramycin für die topische ophthalmische anwendung | |
| UY29249A1 (es) | Agentes citotóxicos que comprenden taxanos nuevos | |
| ATE427122T1 (de) | Behandlung von dermatitis mit dehydroepiandrosteron-glucocorticoid- kombinationen | |
| DK1175433T3 (da) | Androgenglycosider og androgen aktivitet deraf | |
| CY1112973T1 (el) | Περαιτερω κρυσταλλικες μορφες ροσταφουροξινης | |
| PL1827398T3 (pl) | Transdermalny system terapeutyczny z dającym się aktywować przesyceniem i kontrolowanym transportem na zasadzie przenikania | |
| UY28746A1 (es) | Moduladores de receptores de androgenos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |